MedPath

Medical University of South Carolina

Medical University of South Carolina logo
🇺🇸United States
Ownership
Private
Established
1955-01-01
Employees
10K
Market Cap
-
Website
https://www.muschealth.com

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Phase 2
Completed
Conditions
Osteoporosis
Interventions
First Posted Date
2005-12-01
Last Posted Date
2011-01-19
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
22
Registration Number
NCT00259857
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Phase 4
Completed
Conditions
Social Phobia
Alcohol Use Disorder
Alcohol Abuse
Social Anxiety Disorder
Alcohol Dependence
Interventions
Drug: Placebo
Drug: Paroxetine
First Posted Date
2005-10-30
Last Posted Date
2018-09-27
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
42
Registration Number
NCT00246441
Locations
🇺🇸

Medical University of South Carolina, Institute of Psychiatry, Charleston, South Carolina, United States

Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Interventions
Behavioral: Health Education Control Program (CTL)
Behavioral: Mindfulness Meditation (MM) Program
Behavioral: Lifeskills Program (LP)
First Posted Date
2005-10-19
Last Posted Date
2012-12-17
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
283
Registration Number
NCT00241813
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1

Phase 2
Completed
Conditions
Cocaine Dependence
Interventions
Drug: Matching Placebo
Drug: Modafinil
First Posted Date
2005-09-22
Last Posted Date
2019-04-10
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
123
Registration Number
NCT00218387
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1

Phase 2
Completed
Conditions
Cocaine Dependence
Interventions
Drug: Matching Placebo
Drug: N-Acetylcysteine
First Posted Date
2005-09-22
Last Posted Date
2019-01-15
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
111
Registration Number
NCT00218491
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Drug Interactions and Bioavailability of Cranberry

Phase 1
Completed
Conditions
Drug Interactions
Healthy
First Posted Date
2005-09-20
Last Posted Date
2018-05-25
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
16
Registration Number
NCT00200759
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

An Assessment of Milk Thistle Pharmacokinetics and Drug Interactions

Completed
Conditions
Healthy
First Posted Date
2005-09-20
Last Posted Date
2018-07-17
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
32
Registration Number
NCT00200798
Locations
🇺🇸

Medical University of South Carolina, GCRC, Charleston, South Carolina, United States

Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone

Phase 3
Completed
Conditions
Alcohol Dependence
Interventions
First Posted Date
2005-09-16
Last Posted Date
2018-06-07
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
150
Registration Number
NCT00183196
Locations
🇺🇸

Medical University of South Carolina, Center for Drug and Alcohol Programs, Charleston, South Carolina, United States

Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

Phase 2
Completed
Conditions
Alcohol Dependence
First Posted Date
2005-09-16
Last Posted Date
2010-05-05
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
160
Registration Number
NCT00183222
Locations
🇺🇸

Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, South Carolina, United States

Aripiprazole Effects on Alcohol Reactivity and Consumption

Phase 2
Completed
Conditions
Alcohol Dependence
First Posted Date
2005-09-16
Last Posted Date
2010-05-05
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
30
Registration Number
NCT00183235
Locations
🇺🇸

Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath